You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《異動股》藥明系股價高開後倒跌6%-7% BIO轉(車太)支持生物安全法案
美國生物技術創新組織(BIO)轉(車太)支持《生物安全法案》,並採取措施剔除藥明康德(02359.HK)的會員資格。 藥明系今早股價高開很快掉頭向下,且交投活動,尤其是藍籌藥明康德及藥明生物(02269.HK)高開4.5%及3.3%,高見53.75元及19.42元遇阻,掉頭低見47.5元及16.94元,現報47.55元及17.3元,倒跌7%及6.5%,成交已達621萬股及4,017萬股。 藥明合聯(02268.HK)高見21元遇阻,掉頭倒跌6%,現報18.56元,成交已達319萬股。 BIO新任行政總裁John Crowley致函美國眾議院美中戰略競爭特別委員會,稱將支持《生物安全法案》,並會與國會議員合作推動這項立法。前任BIO行政總裁Rachel King曾於上月敦促美中戰略競爭特別委員會重新考慮法案,並對法案明確點名公司提出質疑。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account